Vimarsana
Biggest News Aggregation in the World

Page 9 - Michael Polark News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Polark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Polark Today - Breaking & Trending Today

ResMed (RMD) Q2 2022 Earnings Call Transcript - Vimarsana News

ResMed (RMD) Q2 2022 Earnings Call Transcript

RMD earnings call for the period ending December 31, 2021.

Source: fool.com
Inspire Medical Systems, inc (INSP) Q3 2021 Earnings Call Transcript - Vimarsana News

Inspire Medical Systems, inc (INSP) Q3 2021 Earnings Call Transcript

INSP earnings call for the period ending September 30, 2021.

Source: fool.com
Steris (STE) Q2 2022 Earnings Call Transcript - Vimarsana News

Steris (STE) Q2 2022 Earnings Call Transcript

STE earnings call for the period ending September 30, 2021.

Source: fool.com
Sotera Health Company (SHC) Q1 2021 Earnings Call Transcript - Vimarsana News

Sotera Health Company (SHC) Q1 2021 Earnings Call Transcript

Sotera Health Company (SHC) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Sotera Health Company (NASDAQ: SHC) Q1 2021 Earnings Call Good morning. This is Gigi, and welcome to Sotera Health's first-quarter 2021 results call. You may find today's press release and accompanying supplemental slides in the Investors section of the company's website at soterahealth.com. This webcast is being recorded, and a replay will be available on the Investors section of the Sotera Health website. On the call today are M...

Source: msn.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Inspire Medical Systems (NYSE: INSP), Amgen (NASDAQ: AMGN) and Biogen (NASDAQ: BIIB) - Vimarsana News

Analysts Have Conflicting Sentiments on These Healthcare Companies: Inspire Medical Systems (NYSE: INSP), Amgen (NASDAQ: AMGN) and Biogen (NASDAQ: BIIB)

Inspire Medical Systems (INSP) In a report issued on April 22, Michael Polark from Robert W. Baird maintained a Buy rating on Inspire Medical Systems, with a price target of $260.00. The company’s shares closed last Friday at $227.68, close to its 52-week high of $252.25. According to TipRanks.com, Polark is a 4-star analyst with an average return of 17.3% and a 72.4% success rate. Polark covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Irhythm Technologies, and Intuitive Surgical. The word on The Street in general, suggests a Strong Buy analyst con...